US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Pre-market: 315.727.39+2.40%05:45 EDT

Volume:355.16K

Turnover:107.82M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.95

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.72%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts’ Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

Foundation Healthcare posts strong 1H 2026 growth and accelerates regional expansion

Health Care Down on Cyclical Bias - Health Care Roundup

Vital Healthcare Manager Ceases to Be Substantial Holder in Property Trust

Press Release: Elutia Secures up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results

Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)

Health Care Roundup: Market Talk

Insulet (PODD) Receives a Hold from Citi

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)

Citi Remains a Buy on Vor Biopharma (VOR)

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)

Press Release: Radnostix, Inc. Reports Fy2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition

Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies

Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":355161,"hourTrading":{"tag":"盘前","latestPrice":315.72,"preClose":308.33,"latestTime":"05:45 EDT","volume":268,"amount":83222.71804,"timestamp":1787651112512,"change":7.39,"changeRate":0.023968,"amplitude":0.023222},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Pre-Mkt","change":-8.87,"latestTime":"08-25 05:57:51 EDT","open":314.79,"high":315.4,"low":293,"amount":107824162.61835,"amplitude":0.070618,"askPrice":320.04,"askSize":100,"bidPrice":314,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":308.33,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.0033,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":315.72,"preClose":308.33,"latestTime":"05:45 EDT","volume":268,"amount":83222.71804,"timestamp":1787651112512,"change":7.39,"changeRate":0.023968,"amplitude":0.023222},"postHourTrading":{"tag":"盘后","latestPrice":308.6,"preClose":308.33,"latestTime":"19:56 EDT","volume":2524,"amount":779026.005,"timestamp":1787615773057,"change":0.27,"changeRate":0.000876,"amplitude":0.011327},"volumeRatio":0.7014693617420298,"impliedVol":0.977,"impliedVolPercentile":0.76},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7014693617420298,"shares":2124486,"dividePrice":1.0175,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"committee":0.333333,"eps":0,"divideRate":0.0033,"volume":355161,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659112995","title":"Analysts’ Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112995?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:50","pubTimestamp":1786697404,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC) and Kuros Biosciences (CSBTF) with bulli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alcon-alc-kuros-biosciences-csbtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alcon-alc-kuros-biosciences-csbtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","BK4581","BK4137","HCSG","ALC","LU0128526141.USD","LU2265009873.SGD","XBI","CSBTF","BK4534","BK4585","XLV","BK4588","LU0029874061.USD","BK4139","LABU","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156611","title":"Foundation Healthcare posts strong 1H 2026 growth and accelerates regional expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156611","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156611?lang=en_us&edition=fundamental","pubTime":"2026-08-14 14:22","pubTimestamp":1786688535,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Foundation Healthcare Holdings Limited ( ($SG:FHH) ). Foundation Healthcare reported first-half 2026 revenue gr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/foundation-healthcare-posts-strong-1h-2026-growth-and-accelerates-regional-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/foundation-healthcare-posts-strong-1h-2026-growth-and-accelerates-regional-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4585","LU0128526141.USD","BK4588","BK4581","BK4209","HCSG","XLV","XBI","SG","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160096","title":"Health Care Down on Cyclical Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160096","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160096?lang=en_us&edition=fundamental","pubTime":"2026-08-14 05:03","pubTimestamp":1786654980,"startTime":"0","endTime":"0","summary":"Health-care companies ticked down as traders rotated back into cyclical sectors after relatively benign inflation data.Roche Holdings is pushing forward with a longstanding plan to enter the gene-sequencing business, 10 years after a failed takeover bid for Illumina.The Food and Drug Administration granted emergency-use authorization to Zoetis for a drug that treats New World screwworm infestations in dogs and puppies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","LABU","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659160719","title":"Vital Healthcare Manager Ceases to Be Substantial Holder in Property Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2659160719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659160719?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:47","pubTimestamp":1786654034,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) has provided an update. Vital Healthcare Properties Management Limited has disclosed that it no longer hold...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-manager-ceases-to-be-substantial-holder-in-property-trust?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-manager-ceases-to-be-substantial-holder-in-property-trust?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","LABU","XBI","BK4585","BK4588","HCSG","LU0029874061.USD","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659624541","title":"Press Release: Elutia Secures up to $26 Million to Fund NXT-41x Through Commercial Launch; Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659624541","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659624541?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:10","pubTimestamp":1786651800,"startTime":"0","endTime":"0","summary":"-- Funded through launch: secured up to $26 million of capital without an. -- The unmet need is real: 86% of surgeons surveyed say the matrices they. NXT-41x; 92% responded they would champion it at their hospital value. -- On track: NXT-41 FDA clearance decision expected in 4Q 2026; NXT-41x FDA. \"We believe we are now funded through the anticipated. clearance and full commercial launch of NXT-41x, our. and launch, surgeon interest in NXT-41x has exceeded. to execute.\"Capital Secured to Support NXT-41x Through Clearance and Commercial LaunchElutia has secured up to $26 million of additional capital to support the Company through the anticipated clearance of NXT-41x and its first full year of commercial launch in 2028, without an equity offering:-- $15 million credit facility, including $10 million funded at closing and. an additional $5 million available following NXT-41x FDA clearance. and commercial milestone paymentsIn addition, the Company anticipates receiving the full $8 million ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0058720904.USD","LU0312595415.SGD","LU0302445910.USD","ICLN","LU0728928796.USD","ELUT","BK4139","IE00B19Z3B42.SGD","LU1261432733.SGD","LU0289739699.SGD","NXT","LU0823414551.USD","LU2357125470.USD","FRNW","LU0053671581.USD","BK4588","LU1059921491.USD","LABU","BK4096","LU1978683503.SGD","LU2294711713.HKD","LU2506951792.HKD","BK4196","VCLN","LU2275660780.HKD","CTEC","LU0124384867.USD","LU0868494617.USD","TAN","LU2249611893.SGD","BK4585","BK4596","LU2298322129.HKD","IE0002270589.USD","LU0823414478.USD","LU0724618433.USD","LU1983299162.USD","CI","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659857162","title":"Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2659857162","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659857162?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:01","pubTimestamp":1786651260,"startTime":"0","endTime":"0","summary":"Company launches Flora Sync LF5, the company's first directly commercialized product, began generating revenue in July DARE to PLAY Sildenafil Cream progressing toward national dispensing and initial ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344879/30757/en/dar%C3%A9-bioscience-reports-second-quarter-2026-results-and-highlights-commercial-inflection-as-multi-product-women-s-health-strategy-advances.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4007","DARE","LABU","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659668161","title":"Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659668161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659668161?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:00","pubTimestamp":1786644021,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Achieve Life Sciences (ACHV) and Idexx Laboratories ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-achieve-life-sciences-achv-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-achieve-life-sciences-achv-and-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GB00B4QBRK32.GBP","IDXX","LABU","BK4504","LU0690374961.EUR","XLV","BK4567","LU0170899867.USD","LU0029874061.USD","LU2404859667.USD","HCSG","ACHV","LU0128526141.USD","GB00B4LPDJ14.GBP","LU2404859741.USD","LU0345774631.USD","BK4581","LU1941712264.USD","LU1291159041.SGD","LU1941712348.USD","BK4082","BK4585","BK4588","XBI","LU1989771016.USD","LU0690374615.EUR","BK4139","BK4137","PAWZ","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659691971","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659691971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659691971?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:20","pubTimestamp":1786641612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4082","BK4588","XLV","BK4139","LABU","CADL","LU0128526141.USD","XBI","BK4581","BK4137","LNSR","HCSG","PYXS","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169563","title":"Analysts Conflicted on These Healthcare Names: Fate Therapeutics (FATE) and Mediwound (MDWD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169563?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:50","pubTimestamp":1786639807,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE) and Mediwound (MDWD). Fat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-fate-therapeutics-fate-and-mediwound-mdwd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XBI","BK4007","XLV","HCSG","BK4585","FATE","BK4581","BK4139","BK4137","LU0128526141.USD","BK4588","MDWD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659461166","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2659461166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659461166?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:20","pubTimestamp":1786638000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1158 ET - Drugmakers are delaying or forgoing the launch of new ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","XBI","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166442","title":"Insulet (PODD) Receives a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166442?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:15","pubTimestamp":1786637746,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Hold rating on Insulet today and set a price target of $150.00. Wuensch covers the Healthcare sector, focu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/insulet-podd-receives-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LABU","BK4585","XLV","BK4581","LU2065171402.SGD","XBI","LU1084165304.USD","LU2065170008.USD","LU2324357040.USD","LU1261432733.SGD","LU2065169927.USD","BK4566","BK4082","LU1119994496.HKD","LU2065171311.SGD","LU0728928796.USD","PODD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166348","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166348?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:00","pubTimestamp":1786636814,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE) and Biogen (BIIB). Apog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B19Z9P08.USD","LU0320765992.SGD","XLV","IE00B894F039.SGD","LU0109394709.USD","LU0029874061.USD","LU0234570918.USD","BK4532","BK4139","BMED","IE00B19Z9Z06.USD","PBE","LU0128526141.USD","APGE","XBI","LU0053671581.USD","HCSG","BIIB","SBIO","LABU","BK4581","BK4588","BK4533","LU0889565916.HKD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816653","title":"Citi Remains a Buy on Vor Biopharma (VOR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816653?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:55","pubTimestamp":1786636543,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Vor Biopharma today and set a price target of $50.00. Meacham covers the Healthcare sector, f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-vor-biopharma-vor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LABU","BK4581","VOR","XBI","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663051","title":"Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663051","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663051?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:50","pubTimestamp":1786636209,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Liquidia Technologies (LQDA), AbbVie (ABBV) and Esta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-liquidia-technologies-lqda-abbvie-abbv-and-establishment-labs-holdings-esta-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930573.SGD","LU0198837287.USD","LABU","IE0009355771.USD","LU1934455194.USD","LU0965509010.AUD","LU0124676726.USD","FHLC","IE00B4R5TH58.HKD","BK4559","IYH","LU0965508806.USD","PPH","PJP","SG9999011175.SGD","LU2237443978.SGD","LU0795875169.SGD","XLV","IE00BLSP4239.USD","JDOC","HCSG","LQDA","TRUH","AGNG","LU0942090050.USD","LU2089283258.USD","IXJ","LU0256863811.USD","LU0058720904.USD","IE00BN8TJ469.HKD","SG9999015978.USD","MEDX","IE00BVYPNW00.USD","BK4585","FTXH","RXL","XBI","VHT","LU0545039389.USD","GLAM","IE000F7OJYX1.SGD","LU0965509283.SGD","LU0949170772.SGD","LU1989772840.SGD","LU0738911758.USD","LU2125909247.SGD","IE0004445239.USD","ESTA","ABBV","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663411","title":"Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:46","pubTimestamp":1786635988,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Acumen Pharmaceuticals today and set a price target of $4.00. Meacham covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","XLV","ABOS","LABU","XBI","BK4581","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165757","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165757?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:40","pubTimestamp":1786635611,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4139","SYRE","XLV","LFSC","BK4137","LU2324357040.USD","LABU","LU0128526141.USD","PSIL","LU0029874061.USD","BK4585","BK4588","BK4082","CMPS","LU2065731478.USD","BK4581","TMDX","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659416370","title":"Press Release: Radnostix, Inc. Reports Fy2026 2nd Quarter and Six Months Results - Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2659416370","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659416370?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:02","pubTimestamp":1786633320,"startTime":"0","endTime":"0","summary":"IDAHO FALLS, Idaho, Aug. 13, 2026 /PRNewswire/ -- Radnostix, Inc.   , a manufacturer of radioisotope-focused technologies for medical, industrial, and research applications, today announced its financial results for the second quarter and six months ended June 30, 2026 and the filing of its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission.Second Quarter and First Half 2026 Financial and Operational Summary-- Total revenue for the three months ended June 30, 2026 was $2.67 million,a 27% decrease from $3.66 million in the prior-year period. Revenue for. the six months ended June 30, 2026 was $5.05 million, also down 27% from. $6.89 million in the first half of 2025. The declines were driven. Theranostics Products initiated in the first quarter and Cobalt Products. 2026, expanding the Medical Devices segment portfolio.Shahe Bagerdjian, President and Chief Executive Officer, commented: \"The second quarter continued to reflect the temporary but significant impa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INIS","LABU","BK4588","BK4121","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165831","title":"Alto Neuroscience, Inc. (ANRO) Receives a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165831","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165831?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:45","pubTimestamp":1786632344,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on Alto Neuroscience, Inc. today and set a price target of $40.00. Tsai covers the Healthcare...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alto-neuroscience-inc-anro-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alto-neuroscience-inc-anro-receives-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4585","XLV","BK4588","ANRO","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659638163","title":"Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2659638163","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659638163?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:41","pubTimestamp":1786632060,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings Inc  is currently at $10.64, up $1.59 or 17.51%--Would be highest close since July 23, 2021, when it closed at $10.84--On pace for largest percent increase since Aug. 7, 2025, when it rose 49.36%--Currently up two consecutive days; up 18.83% over this period--Best two day stretch since the two days ending Aug. 8, 2025, when it rose 57.84%--Up 13.26% month-to-date--Up 30.17% year-to-date--Down 17.49% from its all-time closing high of $12.89 on June 14, 2021--Up 47.71% from 52 weeks ago , when it closed at $7.20--Would be a new 52-week closing high--Up 70.98% from its 52-week closing low of $6.22 on April 10, 2026--Traded as high as $10.80; highest intraday level since July 26, 2021, when it hit $10.99--Up 19.34% at today's intraday high; largest intraday percent increase since Aug. 7, 2025, when it rose as much as 59.38%All data as of 10:38:37 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4581","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4137","LU0128526141.USD","BK4539","AVAH","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168244","title":"Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:10","pubTimestamp":1786630208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Connect Biopharma Holdings (CNTB) and Biomea Fusion ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BMEA","XLV","BK4139","LABU","LU0128526141.USD","XBI","BK4581","BK4137","CNTB","HCSG","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":15,"totalSize":398,"code":"91000000","status":"200"}]}}